Drugs / CD1579
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02073461 | Mar → Oct 2014 | acne | Galderma R&D | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT01688531 Comparator | Aug 2012 → Sep 2013 | acne | Galderma R&D | Completed | No outcome recorded |
| Phase 3 | NCT02073448 Comparator | Mar → Oct 2014 | acne | Galderma R&D | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD1579 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02073461 ↗ |